Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 468 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
33 Мб
Скачать
20 Gender-Afrming Facial Surgery: Ofce-Based Procedures
https://t.me/medicina_free
Fig. 20.11 Before (left) and after (right) feminizing cheek injections with hyaluronic acid ller. Note more rounded malar projection post-ller placement and improvement in facial taper from midface to lower face
365
other feminization procedures. The use of resorbable llers offers the patients the unique opportunity for instant results and time to see if they are interested in a more permanent solution. For female to male patients, llers are used for augmenting the mandibular angle projection laterally and for temporary chin augmentation (Fig.20.11).
Summary
The facial gender transition process is a long one. Certainly there are some centers performing all surgical procedures at one time, but a long-standing relationship with the patient can be benecial for several reasons. (1) A gradual transition is some­times more accepted by the patient and their close contacts. (2) The wait for funding or insurance coverage can delay major surgery, so ofce adjunctive procedure such as these mentioned here can allow the patient to have a an easier social transition while awaiting major skeletal recontouring procedures. (3) Fine-tuning skeletal recontouring can be completed with in-ofce procedures that both improve the appearance of aging and also target minor soft tissue differences between the mas­culine and feminine face. (4) Completing these procedures in ofce allows time to develop a rapport and understanding with your patients who, similar to many
366
https://t.me/medicina_free
A. Frazier et al.
cosmetic/aesthetic patients, often have different desires for outcomes; one may be interested in ultra-feminized face, while another may want to focus on only those features that are highly masculinizing and causing misgendering in public areas.
References
1. Joseph A, Cliffe C, Hillyard M, Majeed A.Gender identity and the management of the trans­gender patient: a guide for non-specialists. J R Soc Med. 2017;110(4):144–52.
2. Houssayni S, Nilsen K.Transgender competent provider: identifying transgender health needs, health disparities, and health coverage. Kansas J Med. 2019;11(1):15–9.
3. The World Professional Association for Transgender Health. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012;13(4):165–232.
4. Baldwin A, Dodge B, Schick VR, Light B, Schnarrs PW, Herbenick D, Fortenberry JD. Transgender and genderqueer individuals’ experiences with health care providers: what’s working, what’s not, and where to we go from here? J Health Care Poor Underserved. 2018;29(4):1300–18.
5. Eisenberg ME, McMorris BJ, Rider GN, Gower AL, Coleman E. “It’s king of hard to go to the doctor’s ofce if you’re hated there.” A call for gender-afrming care from transgender and gender diverse adolescents in the United States. Health Soc Care Community. 2020;28:1082–9.
6. Hohman MH, Teixeira J.Transgender surgery of the head and neck. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2021. p.1–26.
7. Flores AR, Herman JL, Gates GJ, Brown TNT.How many adults identify as transgender in the United States? Los Angeles, CA: Williams Institute; 2016. p.1–13.
8. Yarns BC, Abrams JM, Meeks TW, Sewell DD.The mental health of older LGBT adults. Curr Psychiatry Rep. 2016;18(60):5.
9. Sears B, Mallory C, Flores AR, Conron KJ.LGBT people’s experiences of workplace dis­crimination and harassment. Los Angeles, CA: Williams Institute; 2021. p.4.
10. Flores AR, Langton L, Meyer IH, Romero AP.Victimization rates and traits of sexual and gender minorities in the United States: results from the National crime victimization survey,
2017. Sci Adv. 2020;6(6):10.
11. Romero AP, Goldberg SK, Vasquez LA.LGBT people and housing affordability, discrimina­tion, and homelessness. Los Angeles, CA: Williams Institute; 2020. p.1–31.
12. Hage JJ, Becking AG, Graaf FH, Tuinzing DB.Gender-conrming facial surgery: consider­ations on the masculinity and femininity of faces. Plast Reconstr Surg. 1997;99(7):1800. 1803
13. Naini FB.Facial aesthetics: concepts & clinical diagnosis. Hoboken, NJ: Wiley; 2011.
14. Fitzpatrick TH, Siccardi MA.Anatomy, head and neck, Adam’s apple, vol. 2. Treasure Island, FL: StatPearls Publishing; 2021.
15. Flynn W, Vickerton P.Anatomy, head and neck, larynx cartilage, vol. 2. Treasure Island, FL: StatPearls Publishing; 2021.
16. Ko AC, Korn BS, Kikkawa DO.The aging face. Surv Ophthalmol. 2017;62(2):193.
Chapter 21
https://t.me/medicina_free
Advancements inDermal Substitutes forHead andNeck Reconstruction
SarahAnneWong, DinaAmin, JonathonJundt, MichaelR.Markiewicz, SimonYoung
Introduction
Head and neck soft tissue reconstruction is critical to restoring patient health and quality of life following conditions such as trauma, vascular disease, or cancer [1]. Care must be taken to not only restore original function but also esthetics. Thus, the
S. A. Wong Oral and Craniofacial Sciences Graduate Program, School of Dentistry, University of California, San Francisco, CA, USA e-mail: Sarah.Wong@ucsf.edu
D. Amin Division of Oral and Maxillofacial Surgery, Emory University School of Medicine, Dallas, TX, USA e-mail: damin@exchange.tamu.edu
J. Jundt Bernard and Gloria Pepper Katz Department of Oral and Maxillofacial Surgery, School of Dentistry, The University of Texas Health Science Center at Houston, Houston, TX, USA e-mail: Jonathon.Jundt@uth.tmc.edu
M. R. Markiewicz Department of Oral and Maxillofacial Surgery, School of Dental Medicine, University at Buffalo, Buffalo, NY, USA e-mail: mrm25@buffalo.edu
S. Young · J. C. Melville (*) Department of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA e-mail: Simon.Young@uth.tmc.edu; James.C.Melville@uth.tmc.edu
A. Cheng Head and Neck Surgical Associates, Oral, Head and Neck Cancer Center Program, Legacy Cancer Institute, Portland, OR, USA e-mail: chenga@hnsa1.com
, AllenCheng, andJamesC.Melville
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 J. C. Melville et al. (eds.), Advancements and Innovations in OMFS, ENT, and Facial Plastic Surgery, https://doi.org/10.1007/978-3-031-32099-6_21
367
368
https://t.me/medicina_free
S. A. Wong et al.
ideal reconstructive therapy must not only restore proper tissue mobility, strength, and elasticity to carry out everyday functions and withstand common stresses (0.33–1.28MPa), but it must also prevent moisture loss, infection, and cicatrix for­mation and provide a cosmetic, symmetrical, and well color-matched outcome [2]. Although soft tissue reconstruction procedures, such as skin grafting, have been performed for several centuries, over recent decades, surgeons and scientists have collaborated to develop a variety of new tools and techniques that can be used for soft tissue reconstruction [1].
Current soft tissue reconstructive therapies include local advancement aps, microvascular free tissue transfer, split- and full-thickness skin grafting, negative pressure therapy, and dermal substitutes. It is important to note that these techniques vary in the tissue layers they replace. Local aps and free tissue transfers not only replace all three layers of the skin (epidermis, dermis, and hypodermis), but they can also include any combination of skin, fascia, muscle, and bone. Their signicant clinical success has been attributed in large part to the maintenance of a vascular supply to transplanted tissues, either by retaining local vascular connections (local aps) or through anastomosis of transplanted arteries/veins with local blood vessels (free tissue transfers). In contrast, skin grafts do not provide immediate vascular perfusion to the transplanted tissues. Rather, they rely on the gradual formation of local vascular connections at the graft-wound bed interface. Unlike aps, skin grafts only replace the layers of the skin and do not include additional tissues such as fas­cia, muscle, or bone. Skin grafts can be either split-thickness, including epidermis with a variable amount of dermis, or full-thickness, including all layers of the skin. As will be explored in greater depth later in this chapter, dermal substitutes include a wide variety of decellularized allografts, xenografts, and fully synthetic matrices that primarily serve to replace or augment the dermal layer of the skin. Although they are typically used in conjunction with skin grafting, some have been success­fully used alone, as the primary reconstruction modality, and can effect reconstruc­tion of full-thickness epithelial defects. In comparison, negative pressure therapy does not replace any layers of the skin. Rather, it is a technique that uses a vacuum device to exert light, evenly distributed pressure on the wound surface and a conduit for uid removal from the wound site. The negative pressure created by the vacuum helps draw the edges of the wound together and secure any skin grafts or aps that may be present. It also helps to maintain a moist and warm environment conducive to wound healing and to reduce wound edema and infection. The above-listed tech­niques are often used in combination and are selected based on the complexity of each case, which is determined by factors such as anatomical location, depth, and size of the soft tissue defect, vascular supply, the presence or absence of infection, and systemic comorbidities.
Dermal substitutes have been a prolic area of study in recent decades and have been increasingly used for soft tissue reconstruction in the head and neck. Although ap and skin grafting techniques are often preferred, dermal substitutes have dem­onstrated clinical success both when used as the primary reconstruction modality and when used in combination with standard surgical techniques [3]. In contrast to ap and skin grafting, which require a second surgical site, have limited donor
21 Advancements inDermal Substitutes forHead andNeck Reconstruction
https://t.me/medicina_free
369
tissue availability, and cause donor site morbidity, dermal substitutes provide a promising therapeutic alternative, particularly for large soft tissue defects. Dermal substitutes have also demonstrated greater clinical success than some autologous tissue engineering strategies such as cultured epidermal autografts (CEA) and micrografts. Although these techniques have the theoretical advantage of reduced rejection, they also pose signicant disadvantages that hinder their clinical use such as high cost, procedural complexity that often requires a lab facility, and multiple stages of treatment resulting in prolonged treatment duration [4, 5]. These autolo­gous constructs are often fragile and require additional scaffolding in order to pro­vide sufcient mechanical strength. Additionally, CEAS have demonstrated increased risk of infection [6]. In contrast, dermal substitutes, which are not derived from autologous tissues, have been shown to achieve reconstruction of full- thickness epithelial defects while improving pliability and decreasing scar formation [7].
There is a wide spectrum of available dermal substitutes that range from allografts and xenografts to completely synthetic devices (Table21.1). Dermal substitutes are traditionally divided into two categories: biologic and bioarticial. Biologic substi­tutes consist of allografts and xenografts that are entirely derived from living organ­isms and must undergo strict processing, including lyophilization, gamma irradiation, and de-cellularization, in order to render them safe for implantation. In contrast, bioarticial substitutes are either completely or partially synthetic [9]. Dermal substitutes promote wound repair through the process of constructive remodeling [3]. During this process, the body gradually replaces the dermal substi­tute with new tissue, creating a neodermis that resembles the native tissue present prior to injury. Dermal substitutes achieve this through mechanical and molecular means. They serve as scaffolds that provide directional guidance for tissue regen­eration, increase tissue inosculation, and promote plasma imbibition. They also act as reservoirs for molecular signals that stimulate regenerative processes. The extra­cellular matrix (ECM) of dermal substitutes contains a rich supply and variety of growth factors that are released upon matrix degradation, including vascular endo­thelial growth factor (VEGF), platelet-derived growth factor (PDGF-AA, PDGF-BB), transforming growth factor (TGFα, TGFβ1), basic broblast growth factor (bFGF), epidermal growth factor (EGF), placental growth factor (PlGF), granulocyte colony-stimulating factor (G-CSF), anti-inammatory interleukins (IL-4, 6, 8, 10), and tissue inhibitors of metalloproteinases (TIMP 1, 2, 4) [10]. Additionally, peptide fragments often referred to as matricryptins, matrikinins, or matricryptic peptides are generated upon enzymatic breakdown of the device ECM [11, 12]. These peptides often demonstrate bioactivities unique to and more potent than their native, full-length forms [13]. This combination of molecular signals stimulates a wide array of repair processes including angiogenesis, cell migration, differentiation, adhesion, and in some cases immunomodulation. This series of events mimics the natural repair process, and, indeed, many of the growth factors commonly found in dermal substitute ECM are also found in the ECM of natural tissues at different stages of repair.
In this chapter, we review the use of dermal substitutes for soft tissue maxillofa­cial reconstruction, including the most commonly used products, their clinical
370
https://t.me/medicina_free
S. A. Wong et al.
1K are for treating
®
formulations are for
®
1K, and Clarix
®
, and AmnioGuard
®
100, Neox
®
, AmnioGraft
®
100, Clarix
®
Full-thickness burns
Autologous broblasts and keratinocytes on a biopolymer
burns. Can be used alone or in conjunction with split-thickness
skin grafts
Acute, partial-thickness thermal burn wounds in adult patients. Can
be applied in combination with meshed autograft for acute
full-thickness burn wounds in pediatric and adult patients
Full-thickness burns, nasal reconstruction, facial soft-tissue defect
augmentation, free-ap donor site coverage, wound bed graft,
implant to repair and replace damaged or inadequate integumental
tissue, abdominal wall reconstruction, breast reconstruction,
vaginal repair
Debridements, dehiscence, ap donor sites, ulcers (including
decubitus, diabetic foot, and venous leg ulcers), trauma, burns,
management of chronic neuropathic pain, nerve repair, cardiac
regenerative epidermal suspension for
®
sponge
Cultured epidermal autograft Adult and pediatric patients with deep dermal or full-thickness
®
substitutes (CSS)
Epicel
RECELL’s autologous cell harvesting device can be used
by a licensed healthcare professional to prepare an
autologous RES
direct application to burns
Cadaveric skin with acellular dermal matrix and intact
basement membrane
®
®
Recell
Dehydrated human amnion/chorion membrane
Available in sheet, fenestrated, and wrap congurations
®
Amniox
tissue repair following myocardial infarction, plantar fasciitis,
osteoarthritis, amputations, pilonidal cysts, port sites, urothelial
tissue repair
Particularly effective for comorbid patients with complex defects
or delayed healing
Prokera
use in treating ocular surfaces
,
®
, AmnioGraft
®
Cryopreserved human amniotic membrane
Comes in a variety of forms: Prokera
®
BioTissue
Neox
acute, chronic, partial, and full-thickness wounds
Deep partial-thickness burns
1K,
®
100, Neox
®
100, Clarix
®
, Neox
®
1K
®
AmnioGuard
Clarix
Allogeneic cultured keratinocytes and dermal broblasts
in murine collagen
®
Stratagraft
Substitute type Commercial forms Description Uses
Autografts Cultured skin
Table 21.1 Currently available dermal substitutes. Modied from [8]
Allografts AlloDerm
21 Advancements inDermal Substitutes forHead andNeck Reconstruction
https://t.me/medicina_free
Partial- and full-thickness wounds, ulcers (pressure, venous,
diabetic, chronic vascular), surgical wounds (donor sites/grafts,
post-Mohs surgery, post-laser surgery, wound dehiscence),
traumatic wounds (abrasions, lacerations, second-degree burns,
skin tears), tunneled and undermined wounds, and noninfected
draining wounds
Particularly effective when treating wounds challenged with
bacterial infection
Temporary dressing to cover clean partial-thickness burn wounds
and split-thickness donor sites
ulcers, temporary coverage for wounds prior to grafting, test graft
prior to autografting, protective coverage over meshed autografts
Full-thickness burns, neck scar contractures, scar reduction in
buccal defects created when harvesting mucosal grafts for urethral
reconstruction, tongue coverage following partial glossectomies,
nonhealing osteoradionecrosis, medication- related osteonecrosis of
the jaw, coverage of exposed bone, tendon, cartilage, and joints
vascular ulcers, diabetic ulcers, traumatic wounds (including
abrasions, lacerations, and skin tears), surgical wounds (including
donor site/grafts, post-Mohs surgery, podiatric, and wound
dehiscence), draining wounds
Burns, wounds (including traumatic, acute, and chronic),
371
post-Mohs surgery, donor sites/grafts, mucosal defects
venous, chronic vascular, and diabetic), tunneled, undermined
wounds, trauma wounds (including abrasions, lacerations,
second-degree burns, skin tears), draining wounds, surgical wounds
(including donor sites/grafts, post-Mohs surgery, post-laser surgery,
podiatric, wound dehiscence)
abdominal wall repair
(particulate)
®
(sheets), MicroMatrix
®
, Gentrix
®
Porcine urinary bladder mucosal matrix. Consists of two
layers, a lamina propria and a basement membrane
Comes in a variety of forms:
Cytal
®
ACell
Xenografts and
biosynthetic grafts
Bioarticial dressing consisting of a silicone membrane
bonded to a nylon mesh to which porcine dermal collagen
peptides have been bonded
®
Biobrane
EZ Derm™ Aldehyde cross-linked porcine dermis Partial-thickness wounds, burns, donor sites, chronic vascular
Bioarticial device consisting of two layers, an inner
bovine collagen matrix and an outer silicone layer
MariGen™ Decellularized sh skin Partial- and full-thickness wounds, pressure ulcers, chronic
®
Integra
®
Kerecis
Acellular bovine dermal matrix consisting of collagen and
elastin
Porcine small intestinal submucosa extracellular matrix Partial- and full-thickness wounds, ulcers (including pressure,
®
®
MatriDerm
OASIS
Permacol™ Porcine dermal collagen Temporary coverage of partial-thickness burns, hernia, and
372
https://t.me/medicina_free
indications, recommended methods of application, and future developments. Although a comprehensive list of currently available dermal substitutes is available in Table21.1, an exhaustive review of all available products is not our goal. Rather, we aim to compare and contrast the most commonly used dermal substitutes, high­lighting their similarities and differences in design and application, in order to aid our readers in selecting the ideal product for each clinical situation. For the purposes of this chapter, we have limited our discussion to soft tissue reconstruction of the scalp, face, neck, and oral cavity.
S. A. Wong et al.
Common Indications forDermal Substitutes andGlobal Principles ofUse
The most commonly used substitutes include Integra Wound Matrix System, AlloDerm, ACell, and AmnioFix. Primary indications for their use include treat­ment of ap donor sites, scar reduction in acute wounds, granulation bed develop­ment in avulsive wounds, moisture loss prevention, basement membrane replacement in burn wounds, closure of complex chronic wounds associated with diabetes, radia­tion, or high velocity, and treatment of recalcitrant chronic wounds that have been repeatedly operated [1, 4, 7, 1419]. Additional uses for dermal substitutes include rhinoplasty, temporal hollowing, and other volume replacement indications [20]. Dermal substitutes can also be used as biological barriers such as in the prevention of Frey syndrome. In this case, following surgical dissection of the parotid gland, dermal substitutes are applied to separate the parotid bed from the overlying skin, thus preventing the development of aberrant neural connections between the regen­erating parasympathetic axons in the parotid gland and sweat glands in the overly­ing skin [21].
There are several principles that should be applied when using any dermal sub­stitute. Wound bed preparation is paramount to ensuring graft survival. It must be free of necrotic tissue and devitalized bone prior to matrix placement. Vascular sup­ply is critical to new tissue formation. Thus, a wound bed with adequate blood sup­ply must be exposed. This is particularly challenging when the wound bed primarily consists of bone since a bony layer with punctate bleeding must be exposed without damaging underlying structures such as the brain. While debriding to establish this bony layer, it is important to minimize excessive trauma to the bone. This can be accomplished by reserving the use of electric burrs for initial stages of decortication followed by the use of rongeurs or curettes to gradually remove residual cortical and underlying trabecular bone until punctate bleeding is achieved [3]. The outer margin of bony debridement should extend beyond the soft tissue margin of the wound by several millimeters in order to provide adequate peripheral tissue interaction with the dermal substitute [3].
The vast majority of dermal substitutes also require that the wound be free of infection. However, some substitutes such as ACell’s porcine urinary bladder matrix
21 Advancements inDermal Substitutes forHead andNeck Reconstruction
https://t.me/medicina_free
have been successfully used under bacterial challenge [3, 11, 12, 22, 23]. Depending on the case, additional materials may need to be removed from the wound bed prior to matrix placement. For example, in some patients with neurosurgical scalp wounds, especially those who have undergone older meningioma procedures, the materials historically used to treat cranial defects can sometimes interfere with scalp wound healing. Thus, these materials may need to be removed from the exposed wound in order for stable healing to occur [3].
Once inserted, dermal substitutes must achieve intimate contact with the host tissue since the constructive remodeling repair process occurs at the interface between the dermal substitute and the wound bed. The device must remain immobi­lized, and secondary dressings should be applied to secure the device and reduce uid loss in order for healing to successfully progress. Most dermal substitutes require a secondary dressing that typically consists of silicone sheets, or sutured dressings. Optimal secondary dressings should be determined by wound location, size, depth, and user preference. If adequate hydration is not maintained, healing will be delayed. Indeed, if healing is slow and the device appears dry, one should rst attempt to increase the moisture of the dermal substitute device before seeking further treatment [3]. Increased hydration of the wound site can be attained by using hydrogels or Telfa-type dressings [3]. Inner dressings with petrolatum-impregnated gauze or a damp saline layer may also be applied to increase moisture retention at the wound site.
For scalp wounds, it is often customized to shave a 3–4cm rim of hair around the defect. It was believed that this practice improves wound hygiene as well as place­ment of secondary dressings [3]. However, more recently, studies have shown that hair shaving neither benets the surgery itself nor confers any benet against post­operative infection. In fact, data now suggests that hair removal may lead to higher rates of infection [24]. Due to its cosmetic value to patients, it is recommended that hair removal be avoided or minimized as much as possible [24].
Below we explore each of the most commonly used dermal substitutes, listing their specic indications, optimized instructions for application, as well as clinical examples of their use. Recommended protocols are based on instructions from man­ufacturers. However, they have been modied to include suggested techniques that, from our experience, have resulted in the best outcomes.
373
Integra Wound Matrix System
Developed in the 1980s, the Integra Wound Matrix System became the rst com­mercially available dermal substitute. Initially developed as an alternative to skin grafting in burn patients, it has since expanded its application to include routine use in several head and neck reconstructive procedures including treatment of neck scar contractures, reduction of scarring in buccal defects created when harvesting muco­sal grafts for urethral reconstruction, tongue coverage following partial glossecto­mies, and in cases of nonhealing osteoradionecrosis and medication-related
374
https://t.me/medicina_free
osteonecrosis of the jaw [9]. Integra has also been used to cover exposed bone, tendon, cartilage, and joints [25].
Integra is a bioarticial device consisting of two layers, an inner layer of bovine collagen matrix and an outer layer of silicone. The bovine collagen serves to pro­mote tissue inosculation and the development of neodermis, whereas the silicone provides an environmental barrier to reduce moisture loss for up to 2–3weeks post­placement. Following removal of the silicone layer, a thin split thickness skin graft is often recommended. Integra has been shown to signicantly reduce scar forma­tion and to produce a smooth neodermis that readily incorporates with secondary skin grafting.
Below is our recommended protocol for using the Integra matrix system as well as a clinical example demonstrating its use in treating a scalp injury due to dog bite (Fig.21.1).
S. A. Wong et al.
Integra Recommended Protocol
1. Using sterile technique, peel open the outer pouch and gently drop the inner foil
pouch onto a sterile surface. Lay the foil pouch at and peel open.
2. Remove the product, including the protective polyethylene sheets.
3. While holding the product by the tab, remove one polyethylene cover sheet then
turn the product and remove the second.
4. Using the tab, place the product in a basin of sterile saline. Carefully remove the
tab from the product while rinsing for 1–2min. Keep the product in the basin until ready for insertion into the wound.
5. Prepare the wound bed using standard procedures, ensuring that the wound is
free of necrotic tissue or debris. Note: It is important that the wound edges con­tain viable tissue. Surgically debride in order to obtain this if needed.
6. Cut the device to size and immediately apply following wound bed preparation.
Note: It is critical that the collagen layer be in direct contact with the prepared wound. Take care to not apply the product upside down. The silicone layer, iden­tied by black threads, must face the outer surface, away from the wound bed. If placed properly, the black threads identifying the silicone layer will be clearly visible after matrix placement.
7. Firmly secure the Integra matrix using surgical staples, sutures, or other mechan-
ical means. All air bubbles should be carefully removed in order to promote direct contact with the wound.
8. (Optional) Negative pressure wound therapy can be applied at this time. Apply
according to manufacturer’s instructions, paying close attention to contraindica­tions, warnings, and precautions.
9. Use appropriate secondary dressings to ensure device adherence and to protect
the wound area.
Соседние файлы в папке @xirurgi_2025